Traynor Capital Management Inc. Acquires Shares of 160,509 Stereotaxis, Inc. (NYSEAMERICAN:STXS)

Traynor Capital Management Inc. bought a new position in shares of Stereotaxis, Inc. (NYSEAMERICAN:STXS) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 160,509 shares of the company’s stock, valued at approximately $366,000. Traynor Capital Management Inc. owned about 0.19% of Stereotaxis at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of the business. Bank of New York Mellon Corp lifted its position in Stereotaxis by 247.5% during the 2nd quarter. Bank of New York Mellon Corp now owns 189,592 shares of the company’s stock worth $345,000 after acquiring an additional 135,041 shares during the period. Rhumbline Advisers lifted its holdings in shares of Stereotaxis by 645.6% during the second quarter. Rhumbline Advisers now owns 48,251 shares of the company’s stock worth $88,000 after purchasing an additional 41,780 shares during the period. Renaissance Technologies LLC grew its position in Stereotaxis by 46.2% in the 2nd quarter. Renaissance Technologies LLC now owns 488,700 shares of the company’s stock valued at $889,000 after buying an additional 154,400 shares during the last quarter. SG Americas Securities LLC purchased a new position in Stereotaxis during the 3rd quarter worth $39,000. Finally, Charles Schwab Investment Management Inc. boosted its holdings in shares of Stereotaxis by 10.2% in the third quarter. Charles Schwab Investment Management Inc. now owns 167,297 shares of the company’s stock valued at $341,000 after acquiring an additional 15,491 shares in the last quarter. 45.35% of the stock is owned by institutional investors and hedge funds.

Stereotaxis Stock Up 0.9 %

NYSEAMERICAN:STXS opened at $2.21 on Friday. Stereotaxis, Inc. has a fifty-two week low of $1.66 and a fifty-two week high of $3.29.

Stereotaxis (NYSEAMERICAN:STXS) last issued its quarterly earnings data on Monday, November 11th. The company reported ($0.08) EPS for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.03). Stereotaxis had a negative net margin of 85.79% and a negative return on equity of 162.54%. The business had revenue of $9.20 million during the quarter, compared to analyst estimates of $6.80 million. As a group, research analysts forecast that Stereotaxis, Inc. will post -0.26 earnings per share for the current fiscal year.

Stereotaxis Company Profile

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.